Genomic determinants of normal tissue toxicity after radiotherapy for head and neck malignancy: A systematic review

被引:31
作者
Ghazali, Naseem [1 ,2 ]
Shaw, Richard J. [1 ,2 ]
Rogers, Simon N. [1 ,3 ]
Risk, Janet M. [2 ]
机构
[1] Aintree Univ Hosp NHS Fdn Trust, Reg Maxillofacial Unit, Liverpool L9 7AL, Merseyside, England
[2] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Canc Studies, Liverpool L69 3GA, Merseyside, England
[3] Edge Hill Univ, Fac Hlth, Evidence Based Res Practice Ctr, Omskirk, Lancs, England
关键词
Head and neck cancer; Radiotoxicity; Radiotherapy; Toxicity; Genetic polymorphism; Genetic association study; Single nucleotide polymorphism; SINGLE NUCLEOTIDE POLYMORPHISMS; QUALITY-OF-LIFE; DNA-REPAIR GENES; RADIATION-THERAPY; CANCER-PATIENTS; MOLECULAR MARKERS; INTERMEDIATE RISK; PROSTATE-CANCER; ASSOCIATION; RADIOSENSITIVITY;
D O I
10.1016/j.oraloncology.2012.08.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Interindividual variations in radiotoxicity responses exist despite uniform treatment protocols. It is speculated that normal genetic variants, particularly single nucleotide polymorphisms (SNPs) may influence normal head and neck (HN) tissue radiotoxicity. This first-ever systematic review was undertaken to evaluate the association of SNPs with normal HN tissues radiotoxicity. Multiple databases (1950-February 2012) were reviewed using a combination of related keywords and MeSH terms. All published HN radiotoxicity studies with sufficient relevant data for extraction were included. The outcomes evaluated were acute and late radiotoxicity endpoints. Methodological quality assessment based on the STrengthening the REporting of Genetic Association (STREGA) statement was performed. Seven articles from 692 articles searched fulfilled the eligibility criteria. Recruited sample sizes were small (range, 32-140). There were 5/7 case-control studies. All studies used multimodality treatment with heterogeneous radiation parameters. Candidate gene approach was used in all studies. Fourteen SNPs from 9 genes were evaluated from the following pathways: DNA damage response, radiation fibrogenesis and oxidative/xenobiotic metabolism. Acute radiotoxicity events were associated with SNPs of DNA repair genes (OR, 3.01-4.08). SNPs of TGF beta 1 were associated with osteoradionecrosis (OR, 4.2) and subcutaneous fibrosis. Genetic association studies in HN radiotoxicity currently provide hypothesis-generating findings that require validation in larger studies. Future studies must incorporate critical methodological issues and technological improvements, including using a genome-wide approach. Headway is possible through case-pooling of existing clinical trial data which could create a larger sample size of well-characterized treatment and endpoints. Also, on-going HN cancer clinical trials should consider extending their toxicity evaluation to include genetic association studies. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1090 / 1100
页数:11
相关论文
共 50 条
  • [21] Fatigue following head and neck cancer radiotherapy: a systematic review of dose correlates
    Leong, Wun Chin
    Manan, Hanani Abdul
    Hsien, Caryn Chan Mei
    Wong, Yoke Fui
    Yahya, Noorazrul
    SUPPORTIVE CARE IN CANCER, 2024, 32 (07)
  • [22] A systematic review on clinical adaptive radiotherapy for head and neck cancer
    Lindegaard, Anne Marie
    Hakansson, Katrin
    Bernsdorf, Mogens
    Gothelf, Anita B.
    Kristensen, Claus A.
    Specht, Lena
    Vogelius, Ivan R.
    Friborg, Jeppe
    ACTA ONCOLOGICA, 2023, 62 (11) : 1360 - 1368
  • [23] Neurocognitive function following (chemo)radiotherapy for nasopharyngeal cancer and other head and neck cancers: A systematic review
    Iyizoba-Ebozue, Zsuzsanna
    Prestwich, Robin
    Brown, Sarah
    Hall, Emma
    Lilley, John
    Lowe, Matthew
    Thomson, David J.
    Slevin, Finbar
    Boele, Florien
    Murray, Louise
    RADIOTHERAPY AND ONCOLOGY, 2023, 188
  • [24] Very late xerostomia, dysphagia, and neck fibrosis after head and neck radiotherapy
    Baudelet, Margot
    Van den Steen, Leen
    Tomassen, Peter
    Bonte, Katrien
    Deron, Philippe
    Huvenne, Wouter
    Rottey, Sylvie
    De Neve, Wilfried
    Sundahl, Nora
    Van Nuffelen, Gwen
    Duprez, Frederic
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (10): : 3594 - 3603
  • [25] The impact of delivery daytime and seasonality of radiotherapy for head and neck cancer on toxicity burden
    Brolese, Eliane Koller
    Cihoric, Nikola
    Bojaxhiu, Beat
    Sermaxhaj, Burim
    Schanne, Daniel Hendrik
    Mathier, Etienne
    Lippmann, Jana
    Shelan, Mohamed
    Eller, Yannick
    Aebersold, Daniel M.
    Giger, Roland
    Elicin, Olgun
    RADIOTHERAPY AND ONCOLOGY, 2021, 158 : 162 - 166
  • [26] Cochlear implantation after head and neck radiotherapy: A multicentric study and systematic review
    Ariano, Marzia
    Sozzi, Mose
    Lazzerini, Francesco
    De Filippis, Cosimo
    Marioni, Gino
    Franchella, Sebastiano
    Brotto, Davide
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2024, 45 (03)
  • [27] Treatment of late sequelae after radiotherapy for head and neck cancer
    Strojan, Primoz
    Hutcheson, Katherine A.
    Eisbruch, Avraham
    Beitler, Jonathan J.
    Langendijk, Johannes A.
    Lee, Anne W. M.
    Corry, June
    Mendenhall, William M.
    Smee, Robert
    Rinaldo, Alessandra
    Ferlito, Alfio
    CANCER TREATMENT REVIEWS, 2017, 59 : 79 - 92
  • [28] Late gastrointestinal toxicity after radiotherapy for rectal cancer: a systematic review
    Sipaviciute, Agne
    Sileika, Ernestas
    Burneckis, Arvydas
    Dulskas, Audrius
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2020, 35 (06) : 977 - 983
  • [29] Predictors for Weight Loss in Head and Neck Cancer Patients Undergoing Radiotherapy A Systematic Review
    Zhao, Jin-Zhi
    Zheng, Hong
    Li, Li-Ya
    Zhang, Li-Yuan
    Zhao, Yue
    Jiang, Nan
    CANCER NURSING, 2015, 38 (06) : E37 - E45
  • [30] Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer
    Pryor, David I.
    Porceddu, Sandro V.
    Burmeister, Bryan H.
    Guminski, Alex
    Thomson, Damien B.
    Shepherdson, Kristine
    Poulsen, Michael
    RADIOTHERAPY AND ONCOLOGY, 2009, 90 (02) : 172 - 176